{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:34:52Z","timestamp":1793046892783,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","award":["2025-I2M-XHZY-034"],"award-info":[{"award-number":["2025-I2M-XHZY-034"]}],"id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","award":["2024-I2M-ZH-016"],"award-info":[{"award-number":["2024-I2M-ZH-016"]}],"id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430010"],"award-info":[{"award-number":["82430010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300159"],"award-info":[{"award-number":["82300159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470138"],"award-info":[{"award-number":["82470138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["25ZXZSSS00510"],"award-info":[{"award-number":["25ZXZSSS00510"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omta.2026.201832","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:48:27Z","timestamp":1786060107000},"page":"201832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequence-based artificial intelligence-guided inhibitory peptides to counteract AAV neutralizing antibodies in gene therapy"],"prefix":"10.1016","volume":"34","author":[{"given":"Bingqi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-3816","authenticated-orcid":false,"given":"Xiaolei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201832_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","article-title":"Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors","volume":"14","author":"Kruzik","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201832_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.omtm.2020.06.003","article-title":"Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity","volume":"18","author":"Pei","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201832_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/BS9.0000000000000030","article-title":"Advances of adeno-associated virus applied in gene therapy to hemophilia from bench work to the clinical use","volume":"1","author":"Pei","year":"2019","journal-title":"Blood Sci."},{"key":"10.1016\/j.omta.2026.201832_bib4","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/S2352-3026(22)00113-2","article-title":"Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial","volume":"9","author":"Xue","year":"2022","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.omta.2026.201832_bib5","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant","volume":"377","author":"George","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201832_bib6","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-Factor VIII Gene Transfer in Severe Hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201832_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70014","article-title":"Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)","volume":"48","author":"Weinstein","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omta.2026.201832_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy","volume":"389","author":"Lek","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201832_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.8.2.14","article-title":"Relationship Between Neutralizing Antibodies Against Adeno-Associated Virus in the Vitreous and Serum: Effects on Retinal Gene Therapy","volume":"8","author":"Lee","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.omta.2026.201832_bib10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","article-title":"AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial","volume":"403","author":"Lv","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201832_bib11","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201832_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/hum.2021.129","article-title":"Repeated Systemic Dosing of Adeno-Associated Virus Vectors in Immunocompetent Mice After Blockade of T Cell Costimulatory Pathways","volume":"33","author":"Zhong","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201832_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005795","article-title":"Overcoming preexisting humoral immunity to AAV using capsid decoys","volume":"5","author":"Mingozzi","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201832_bib14","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","article-title":"IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies","volume":"26","author":"Leborgne","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201832_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101399","article-title":"The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver","volume":"33","author":"Gan","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201832_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103205","article-title":"Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL\/lpr mice","volume":"145","author":"Wang","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.omta.2026.201832_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2012.01.008","article-title":"The DWEYS peptide in systemic lupus erythematosus","volume":"18","author":"Bosch","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omta.2026.201832_bib18","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1128\/JVI.01959-12","article-title":"Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus","volume":"86","author":"Martinez-Navio","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201832_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s43556-022-00085-0","article-title":"A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS\/MS combined with immune repertoire","volume":"3","author":"Yu","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.omta.2026.201832_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.abq3773","article-title":"Broadly neutralizing antibodies target the coronavirus fusion peptide","volume":"377","author":"Dacon","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201832_bib21","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.csbj.2021.03.022","article-title":"The language of proteins: NLP, machine learning & protein sequences","volume":"19","author":"Ofer","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201832_bib22","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41467-022-29443-w","article-title":"Learning meaningful representations of protein sequences","volume":"13","author":"Detlefsen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201832_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2022.100551","article-title":"Accurate prediction of virus-host protein-protein interactions via a siamese neural network using deep protein sequence embeddings","volume":"3","author":"Madan","year":"2022","journal-title":"Patterns"},{"key":"10.1016\/j.omta.2026.201832_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s42256-021-00310-5","article-title":"Expanding functional protein sequence spaces using generative adversarial networks","volume":"3","author":"Repecka","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.omta.2026.201832_bib25","first-page":"9689","article-title":"Evaluating Protein Transfer Learning with TAPE","volume":"32","author":"Rao","year":"2019","journal-title":"Adv Neural Inf Process Syst"},{"key":"10.1016\/j.omta.2026.201832_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s42003-021-02610-3","article-title":"NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRalpha and beta sequence data","volume":"4","author":"Montemurro","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omta.2026.201832_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s42256-021-00383-2","article-title":"Deep learning-based prediction of the T cell receptor-antigen binding specificity","volume":"3","author":"Lu","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.omta.2026.201832_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41592-019-0666-6","article-title":"Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning","volume":"17","author":"Gainza","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201832_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tibtech.2022.11.006","article-title":"Evading and overcoming AAV neutralization in gene therapy","volume":"41","author":"Earley","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omta.2026.201832_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101273","article-title":"Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies","volume":"32","author":"Chhabra","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201832_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101195","article-title":"Use of plasmapheresis to lower anti-AAV antibodies in nonhuman primates with pre-existing immunity to AAVrh74","volume":"32","author":"Potter","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201832_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omta.2026.201832_bib33","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","article-title":"CD-HIT: accelerated for clustering the next-generation sequencing data","volume":"28","author":"Fu","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2026.201832_bib34","series-title":"International Conference on Learning Representations","article-title":"Fixing weight decay regularization in Adam","author":"Loshchilov","year":"2018"},{"key":"10.1016\/j.omta.2026.201832_bib35","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1128\/JVI.02466-08","article-title":"Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors","volume":"83","author":"Hewitt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201832_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101245","article-title":"An investigation of the immune epitopes of adeno-associated virus capsid-derived peptides among hemophilia patients","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:38:27Z","timestamp":1793043507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S3117387X26001679"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201832","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequence-based artificial intelligence-guided inhibitory peptides to counteract AAV neutralizing antibodies in gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201832"}}